Cat Vaccine Market Explained: What Is Fueling Growth To $1.93 Billion By 2030?
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Cat Vaccine Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The cat vaccine market size has shown robust growth in recent years. It is expected to increase from $1.26 billion in 2025 to $1.38 billion in 2026, at a compound annual growth rate (CAGR) of 9.2%. The expansion observed in the historic period can be attributed to a rising incidence of feline infectious diseases, limited availability of advanced vaccines, an increase in pet ownership, the proliferation of veterinary clinics, and government vaccination initiatives.
The cat vaccine market size is projected to experience robust expansion over the coming years. It is anticipated to reach $1.93 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. This anticipated growth during the forecast period is attributable to several factors, including breakthroughs in vaccine technology, a growing preference for recombinant and DNA vaccines, heightened consciousness regarding preventative pet healthcare, the proliferation of online veterinary platforms, and the incorporation of AI and data analytics for disease surveillance. Key trends shaping the market over the forecast duration encompass a wider embrace of essential vaccination initiatives, the continued development of recombinant and DNA vaccines, the broadening scope of veterinary healthcare offerings, an enhanced understanding of pet wellness and illness prevention, and the incorporation of telemedicine alongside remote monitoring solutions in veterinary practice.
Get A Free Sample Report With In-Depth Market Insights:
Cat Vaccine Market Development Factors: What’s Supporting Demand?
The rising occurrence of zoonotic diseases is anticipated to drive the expansion of the cat vaccine market in the future. These diseases are infections transmissible from animals to humans, stemming from pathogens like bacteria, viruses, fungi, or parasites. Their transmission can occur via direct contact, vectors, or polluted surroundings. Examples include Lyme disease, rabies, toxoplasmosis, salmonellosis, brucellosis, among others. The growing incidence of zoonotic diseases is attributed to factors such as climate change, antibiotic resistance, and both illicit and legal wildlife trade. Cat vaccines manage these diseases by lowering the likelihood of human transmission from felines, achieved through immunizing cats against conditions like toxoplasmosis and cat scratch fever. This preventative measure assists in lessening the impact of zoonotic diseases on human well-being, aids public health initiatives, and guarantees a safer habitat for pets and their owners. For example, a report from the Government of the United Kingdom, published in February 2024, indicated that England saw 335 confirmed Lyme disease cases in the fourth quarter of 2023, which was an increase from 273 cases documented in the corresponding period of 2022. Consequently, the rise in zoonotic diseases acts as a driver for the cat vaccine market.
Cat Vaccine Market Segment Outlook: Which Categories Are Growing Fastest?
The cat vaccine market covered in this report is segmented –
1) By Vaccine Type: Modified Or Attenuated Live, Inactivated, Other Vaccine Types
2) By Disease Type: Feline Leukemia, Feline Panleukopenia, Feline Respiratory Diseases, Feline Rabies, Other Disease Types
3) By Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines
4) By Route Of Administration: Injectables, Intranasal, Oral
5) By Distribution Channel: Veterinary Clinics, Pet Stores, Online Retailers
Subsegments:
1) By Modified Or Attenuated Live: Feline Viral Rhinotracheitis (FVR) Vaccine, Feline Calicivirus (FCV) Vaccine, Feline Panleukopenia (FPV) Vaccine
2) By Inactivated: Inactivated Feline Leukemia Virus (FeLV) Vaccine, Inactivated Feline Infectious Peritonitis (FIP) Vaccine
3) By Other Vaccine Types: Recombinant Vaccines, DNA Vaccines, Subunit Vaccines, Combination Vaccines
Cat Vaccine Market Transformation Trends: What Innovations Are Driving Change?
Leading companies in the cat vaccine market are concentrating on developing innovative products like NOBIVAC NXT vaccines, which leverage state-of-the-art Ribonucleic acid (RNA)-particle technology. This technology is intended to boost immune responses, improve vaccine efficacy, and offer specific protection against feline diseases. The cutting-edge Ribonucleic acid (RNA)-particle technology is an inventive method utilizing RNA molecules encapsulated in nanoparticles to deliver genetic instructions to cells, prompting them to generate particular proteins that stimulate a targeted immune response. For example, in June 2024, MSD Animal Health Inc., a US-based pharmaceutical company, launched the NOBIVAC NXT Rabies portfolio, comprising NOBIVAC NXT Feline-3 Rabies and NOBIVAC NXT Canine-3 Rabies. This comprehensive vaccination solution is designed to offer effective protection against rabies in cats and dogs. The NOBIVAC NXT vaccines are developed without adjuvants and preservatives, which enhances their safety profile while upholding their efficacy. These vaccines stimulate both humoral (antibody-mediated) and cell-mediated immune responses, providing broad protection against the rabies virus.
Cat Vaccine Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the cat vaccine market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale, Virbac, HIPRA Corporation, Bioveta AS, Biogénesis Bagó SA, Torigen Pharmaceuticals Inc., Vetoquinol SA, Phibro Animal Health Corporation, IDT Biologika GmbH, Vaxxinova BV, Colorado Serum Company, Huvepharma NV, Bimeda Biologicals, CAVAC, Kyoto Biken Laboratories, Avimex Animal Health, Ringpu Biology, Wuhan Keqian Biology, Pulike Biological Engineering, Chengdu Kanghua Biological Products, Yebio, FATRO
View The Full Cat Vaccine Market Report:
Cat Vaccine Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the cat vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cat vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
